Post-therapy viral set-point abatement following combined antiproliferative and immune-boosting interventions: results from a randomised clinical trial
R. Sobhie Diaz,
L.B. Giron,
J. Galinskas,
J. Hunter,
M. Janini,
I.L. Shytaj,
R. Cauda,
M.C. Sucupira,
J. Maricato,
A. Savarino
Affiliations
R. Sobhie Diaz
Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, Brazil
L.B. Giron
Wistar Institute, Philadelphia, USA
J. Galinskas
Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, Brazil
J. Hunter
Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, Brazil
M. Janini
Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, Brazil
I.L. Shytaj
Heidelberg University Hospital, Department of Infectious Diseases, Heidelberg, Germany
R. Cauda
Institute of Infectious Diseases, Gemelli Hospital, Catholic University of Sacred Heart, Rome, Italy
M.C. Sucupira
Federal University of Sao Paulo, Infectious Diseases Department, Sao Paulo, Brazil
J. Maricato
Federal University of Sao Paulo, Infectious Diseases Department, Sao Paulo, Brazil
A. Savarino
Department of Infectious Diseases, Italian Institute of Health, Rome, Italy
